Eyüpoğlu ND, Çınar OE, Aksu S, Büyükaşık Y, Sayınalp N, Demiroğlu H, Göker H, Özcebe Oİ, Haznedaroğlu İC. Event-free Survival in Patients with Chronic Myeloid Leukemia Receiving Front-line Imatinib Mesylate. Acta Medica [Internet]. 2022 Jun. 15 [cited 2024 Nov. 23];53(3):277-83. Available from: https://actamedica.org/index.php/actamedica/article/view/745